featured
Vinorelbine/Lapatinib Is Safe and Effective in Patients With HER2+ Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Anticancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Systematic Review and Meta-Analysis of the Combination of Vinorelbine and Lapatinib in Patients With Her2-Positive Metastatic Breast Cancer
Anticancer Res. 2019 Jul 01;39(7)3295-3301, A Stravodimou, IA VoutsadakisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.